The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells
Open accessAbstract
Previous studies have demonstrated that a small subset of cancer cells is capable of tumor initiation. The existence of tumor initiating cancer stem cells (CSCs) has several implications in terms of future cancer treatment and therapies. However, recently, several researchers proposed that differentiated cancer cells (non-CSCs) can convert to stem-like cells to maintain equilibrium. These results imply that removing CSCs may prompt non-CSCs in the tumor to convert into stem cells to maintain the equilibrium. Interleukin-6 (IL-6) has been found to play an important role in the inducible formation of CSCs and their dynamic equilibrium with non-stem cells. In this study, we used CSC-like human breast cancer cells and their alternate subset non-CSCs to investigate how IL-6 regulates the conversion of non-CSCs to CSCs. MDA-MB-231 and MDA-MB-453 CSC-like cells formed mammospheres well, whereas most of non-stem cells died by anoikis and only part of the remaining non-stem cells produced viable mammospheres. Similar results were observed in xenograft tumor formation. Data from cytokine array assay show that IL-6 was secreted from non-CSCs when cells were cultured in ultra-low attachment plates. IL-6 regulates CSC-associated OCT-4 gene expression through the IL-6-JAK1-STAT3 signal transduction pathway in non-CSCs. Inhibiting this pathway by treatment with anti-IL-6 antibody (1 μg/ml) or niclosamide (0.5–2 μM)/LLL12 (5–10 μM) effectively prevented OCT-4 gene expression. These results suggest that the IL-6-JAK1-STAT3 signal transduction pathway plays an important role in the conversion of non-CSCs into CSCs through regulation of OCT-4 gene expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
O’Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007) · Nature · doi:10.1038/nature05372 · Cited by 4,087
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
TGF-β signalling from cell membrane to nucleus through SMAD proteins
Heldin, C.-H., Miyazono, K., & ten Dijke, P. (1997) · Nature · doi:10.1038/37284 · Cited by 3,696
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Visvader, J. E., & Lindeman, G. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2499 · Cited by 3,429
CA: A Cancer Journal for Clinicians
(2010) · CA A Cancer Journal for Clinicians · doi:10.3322/(issn)1542-4863 · Cited by 2,538
Signaling Through Scaffold, Anchoring, and Adaptor Proteins
Pawson, T., & Scott, J. D. (1997) · Science · doi:10.1126/science.278.5346.2075 · Cited by 2,256
Metastasis: a question of life or death
Mehlen, P., & Puisieux, A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1886 · Cited by 1,863
Dimerization of cell surface receptors in signal transduction
Heldin, C.-H. (1995) · Cell · doi:10.1016/0092-8674(95)90404-2 · Cited by 1,634
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
Gupta, P. B., Fillmore, C. M., Jiang, G., Shapira, S. D., Tao, K., Kuperwasser, C., & Lander, E. S. (2011) · Cell · doi:10.1016/j.cell.2011.07.026 · Cited by 1,475
Breast cancer statistics, 2011
DeSantis, C., Siegel, R., Bandi, P., & Jemal, A. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20134 · Cited by 1,326
Cancer Stem Cells: Models and Concepts
Dalerba, P., Cho, R. W., & Clarke, M. F. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.58.062105.204854 · Cited by 1,274
The JAK-STAT Signaling Pathway: Input and Output Integration
Murray, P. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2623 · Cited by 1,179
Akira, S., Nishio, Y., Inoue, M., Wang, X.-J., We, S., Matsusaka, T., Yoshida, K., Sudo, T., Naruto, M., & Kishimoto, T. (1994) · Cell · doi:10.1016/0092-8674(94)90235-6 · Cited by 1,019
Hope, K. J., Jin, L., & Dick, J. E. (2004) · Nature Immunology · doi:10.1038/ni1080 · Cited by 968
Sansone, P., Storci, G., Tavolari, S., Guarnieri, T., Giovannini, C., Taffurelli, M., Ceccarelli, C., Santini, D., Paterini, P., Marcu, K. B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32533 · Cited by 779
Cytokine Signaling Through Nonreceptor Protein Tyrosine Kinases
Taniguchi, T. (1995) · Science · doi:10.1126/science.7716517 · Cited by 692
Iliopoulos, D., Hirsch, H. A., Wang, G., & Struhl, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018898108 · Cited by 643
Beyond tumorigenesis: cancer stem cells in metastasis
Li, F., Tiede, B., Massagué, J., & Kang, Y. (2007) · Cell Research · doi:10.1038/sj.cr.7310118 · Cited by 620
Breast cancer stem cells, cytokine networks, and the tumor microenvironment
Korkaya, H., Liu, S., & Wicha, M. S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57099 · Cited by 616
Stem cells in normal breast development and breast cancer
Dontu, G., Al‐Hajj, M., Abdallah, W. M., Clarke, M. F., & Wicha, M. S. (2003) · Cell Proliferation · doi:10.1046/j.1365-2184.36.s.1.6.x · Cited by 578
Stem cells in normal breast development and breast cancer
Wicha, M., Dontu, G., Al-Hajj, M., & Clarke, M. (2003) · Breast Cancer Research · doi:10.1186/bcr709 · Cited by 537
Oct-4 Expression Maintained Cancer Stem-Like Properties in Lung Cancer-Derived CD133-Positive Cells
Chen, Y.-C., Hsu, H.-S., Chen, Y.-W., Tsai, T.-H., How, C.-K., Wang, C.-Y., Hung, S.-C., Chang, Y.-L., Tsai, M.-L., Lee, Y.-Y., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002637 · Cited by 508
Self-citationGrandis, J. R., Drenning, S. D., Chakraborty, A., Zhou, M. Y., Zeng, Q., Pitt, A. S., & Tweardy, D. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3785 · Cited by 507
Colon Cancer Stem Cells: Promise of Targeted Therapy
Todaro, M., Francipane, M. G., Medema, J. P., & Stassi, G. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.063 · Cited by 443
Activation and Association of Stat3 with Src in v-Src-Transformed Cell Lines
Cao, X., Tay, A., Guy, G. R., & Tan, Y. H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1595 · Cited by 359
Niemand, C., Nimmesgern, A., Haan, S., Fischer, P., Schaper, F., Rossaint, R., Heinrich, P. C., & Müller-Newen, G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.3263 · Cited by 357
Targeting Breast Cancer Stem Cells
Liu, S., & Wicha, M. S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.5388 · Cited by 356
Targeted therapy for cancer stem cells: the patched pathway and ABC transporters
Lou, H., & Dean, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210200 · Cited by 239
Berishaj, M., Gao, S. P., Ahmed, S., Leslie, K., Al-Ahmadie, H., Gerald, W. L., Bornmann, W., & Bromberg, J. F. (2007) · Breast Cancer Research · doi:10.1186/bcr1680 · Cited by 236
Recent advances in cancer stem cells
Cho, R. W., & Clarke, M. F. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.01.017 · Cited by 227
HCMV-Encoded Chemokine Receptor US28 Mediates Proliferative Signaling Through the IL-6–STAT3 Axis
Slinger, E., Maussang, D., Schreiber, A., Siderius, M., Rahbar, A., Fraile-Ramos, A., Lira, S. A., Söderberg-Nauclér, C., & Smit, M. J. (2010) · Science Signaling · doi:10.1126/scisignal.2001180 · Cited by 224
Looking ahead in cancer stem cell research
Dick, J. E. (2009) · Nature Biotechnology · doi:10.1038/nbt0109-44 · Cited by 211
Serine/threonine kinase receptors: mediators of transforming growth factor beta family signals.
Massagué, J., & Weis‐Garcia, F. (1996) · PubMed · Cited by 196
Molecular biology of colorectal cancer
Gryfe, R., Bapat, B., Gallinger, S., Swallow, C., Redston, M., & Couture, J. (1997) · Current Problems in Cancer · doi:10.1016/s0147-0272(97)80003-7 · Cited by 193
Cancer Stem Cells and Metastasis: Lethal Seeds
Wicha, M. S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1537 · Cited by 174
Allan, A. L., Vantyghem, S. A., Tuck, A. B., & Chambers, A. F. (2007) · Breast Disease · doi:10.3233/bd-2007-26108 · Cited by 168
Cancer Stem Cells: At the Headwaters of Tumor Development
Ward, R. J., & Dirks, P. B. (2007) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.2.010506.091847 · Cited by 164
Novel therapeutic Strategies for Targeting Liver Cancer Stem Cells
Oishi, N., & Wang, X. W. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.517 · Cited by 161
IL-4-mediated drug resistance in colon cancer stem cells
Todaro, M., Alea, M. P., Scopelliti, A., Medema, J. P., & Stassi, G. (2008) · Cell Cycle · doi:10.4161/cc.7.3.5389 · Cited by 146
Breast cancer stem cells: implications for therapy of breast cancer
Morrison, B. J., Schmidt, C., Lakhani, S. R., Reynolds, B. A., & López, J. A. (2008) · Breast Cancer Research · doi:10.1186/bcr2111 · Cited by 140
Birge, R. B., Knudsen, B. S., Besser, D., & Hanafusa, H. (1996) · Genes to Cells · doi:10.1046/j.1365-2443.1996.00258.x · Cited by 138
PI3K and STAT3: A New Alliance
Vogt, P. K., & Hart, J. R. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0218 · Cited by 132
Auranofin blocks interleukin‐6 signalling by inhibiting phosphorylation of JAK1 and STAT3
Kim, N.-H., Lee, M.-Y., Park, S.-J., Choi, J.-S., Oh, M.-K., & Kim, I.-S. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02679.x · Cited by 125
Mutational analysis of acute-phase response factor/Stat3 activation and dimerization
Sasse, J., Hemmann, U., Schwartz, C., Schniertshauer, U., Heesel, B., Landgraf, C., Schneider-Mergener, J., Heinrich, P. C., & Horn, F. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4677 · Cited by 120
Crucial Role of Interleukin-4 in the Survival of Colon Cancer Stem Cells
Francipane, M. G., Alea, M. P., Lombardo, Y., Todaro, M., Medema, J. P., & Stassi, G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6874 · Cited by 120
Activation of Ras and Other Signaling Pathways by Receptor Tyrosine KinasesPreprint
Schlessinger, J., & Bar-Sagi, D. (1994) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1994.059.01.021 · Cited by 94
Intracellular signalling: Putting JAKs on the kinase MAP
Winston, L. A., & Hunter, T. R. (1996) · Current Biology · doi:10.1016/s0960-9822(09)00445-x · Cited by 94
Tec tyrosine kinase links the cytokine receptors to PI-3 kinase probably through JAK
Takahashi-Tezuka, M., Hibi, M., Fujitani, Y., Fukada, T., Yamaguchi, T., & Hirano, T. (1997) · Oncogene · doi:10.1038/sj.onc.1201071 · Cited by 91
Janus kinases in cytokine signalling
Ihle, J. N., & Marshall, C. J. (1996) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1996.0012 · Cited by 78
Schröer, N., Pahne, J., Walch, B., Wickenhauser, C., & Smola, S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2193 · Cited by 78
Stat3 Mediates Expression of Autotaxin in Breast Cancer
Azare, J., Doane, A. S., Leslie, K., Chang, Q., Berishaj, M., Nnoli, J., Mark, K. G., Al‐Ahmadie, H. A., Gerald, W. L., Hassimi, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027851 · Cited by 72
SD-1029 Inhibits Signal Transducer and Activator of Transcription 3 Nuclear Translocation
Duan, Z., Bradner, J. E., Greenberg, E. F., Levine, R. L., Foster, R., Mahoney, J., & Seiden, M. V. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1330 · Cited by 67
Karakosta, A., Ch, G., Charalabopoulos, A., Peschos, D., Batistatou, A. K., & Charalabopoulos, K. (2005) · PubMed · Cited by 66
Zhang, C., Xu, G., Jia, W., Li, J., Ma, J., Ren, W., Ge, Y., Yu, J.-H., Liu, W., & Wang, W. (2010) · Journal of Surgical Research · doi:10.1016/j.jss.2010.10.030 · Cited by 58
Src family kinases regulate p38 MAPK-mediated IL-6 production in Kupffer cells following hypoxia
Thobe, B. M., Frink, M., Choudhry, M. A., Schwacha, M. G., Bland, K. I., & Chaudry, I. H. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00076.2006 · Cited by 58
Cell-autonomous integrin control of Wnt and Notch signalling during somitogenesis
Rallis, C., Pinchin, S. M., & Ish‐Horowicz, D. (2010) · Development · doi:10.1242/dev.050070 · Cited by 49
Permanently Blocked Stem Cells Derived From Breast Cancer Cell Lines
Sajithlal, G. B., Rothermund, K. D., Zhang, F., Dabbs, D. J., Latimer, J. J., Grant, S. G., & Prochownik, E. V. (2010) · Stem Cells · doi:10.1002/stem.424 · Cited by 48
Oct4-related cytokine effects regulate tumorigenic properties of colorectal cancer cells
Chang, C.-J., Chien, Y., Lu, K., Chang, S., Chou, Y., Huang, C.-S., Chang, C.-H., Chen, K.-H., Chang, Y.-L., Tseng, L., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.024 · Cited by 48
Zhou, W., Grandis, J. R., & Wells, A. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603234 · Cited by 47
Stem cell biology and the cellular pathways of carcinogenesis
Guðjónsson, Þ., & Magnússon, M. K. (2005) · Apmis · doi:10.1111/j.1600-0463.2005.apm_371.x · Cited by 46
HMGB‐1 induces IL‐6 production in human synovial fibroblasts through c‐Src, Akt and NF‐κB pathways
Hou, C., Fong, Y., & Tang, C. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22541 · Cited by 42
Migfilin Interacts with Src and Contributes to Cell-Matrix Adhesion-mediated Survival Signaling
Zhao, J., Zhang, Y., Ithychanda, S. S., Tu, Y., Chen, K., Qin, J., & Wu, C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.045021 · Cited by 37
Su, L., Rao, K., Guo, F., Li, X., Ahmed, A. A., Ni, Y., Grossmann, R., & Zhao, R. (2012) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2012.01.007 · Cited by 20
Cited by
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
Chronic inflammation and cytokines in the tumor microenvironment
Landskron, G., De la Fuente, M., Thuwajit, P., Thuwajit, C., & Hermoso, M. A. (2014) · Journal of Immunology Research · doi:10.1155/2014/149185 · Cited by 1,765
Role of interleukin-6 in cancer progression and therapeutic resistance
Kumari, N., Dwarakanath, B. S., Das, A., & Bhatt, A. N. (2016) · Tumor Biology · doi:10.1007/s13277-016-5098-7 · Cited by 1,092
Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
Phi, L. T. H., Sari, I. N., Yang, Y.-G., Lee, S.-H., Jun, N., Kim, K. S., Lee, Y. K., & Kwon, H. Y. (2018) · Stem Cells International · doi:10.1155/2018/5416923 · Cited by 994
Self-citationObesity and diabetes: the increased risk of cancer and cancer-related mortality
Gallagher, E. J., & LeRoith, D. (2015) · Physiological Reviews · doi:10.1152/physrev.00030.2014 · Cited by 806
Metadata
- Authors
- Kim, S.-Y., Kang, J. W., Song, X., Kim, B. K., Yoo, Y. D., Kwon, Y. T., & Lee, Y. J.
- Venue
- Cellular Signalling
- Publisher
- Elsevier BV
- Published
- 2013-04
- Volume
- 25
- Issue
- 4
- Pages
- 961-969
- ISSN
- 0898-6568 (ISSN-L)
- OpenAlex
- W2025915231
- Cited by
- 297
- References
- 69
- FWCI
- 11.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.